TAGCyx Biotechnologies

About:

TAGCyx Biotechnologies is a company development of highly functional nucleic acid drugs and in-house drug discovery business.

Website: http://tagcyx.com/en/

Top Investors: SMBC Venture Capital, Mizuho Capital, UTEC - The University of Tokyo Edge Capital Partners, Nissay Capital, SBI Group

Description:

TagCyx’s scientific team has established its proprietary Xenoligo® technology platform, allowing high functional oligonucletide drug discovery. The Xenoligo® platform utilizes genetic alphabet expansion by unnatural base-pairs to generate customized nucleic acid suited for therapeutic applications.